FTC sues big pharmacy gain managers over insulin prices The company brought motion against Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating techniques “artificially inflated” the list cost of existence-conserving insulin medicines. Given that some electronic wellness startups funded all through the peak with the investment https://charliezrhxo.blogtov.com/11118523/not-known-factual-statements-about-healthcare-news